ACADIA Pharmaceuticals (ACAD) News Today $20.98 -1.08 (-4.90%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$21.35 +0.37 (+1.76%) As of 07/11/2025 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACAD Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Concurrent Investment Advisors LLC Invests $247,000 in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)July 13 at 3:38 AM | marketbeat.comPrincipal Financial Group Inc. Has $12.54 Million Stock Position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)July 13 at 3:21 AM | marketbeat.comNew York State Teachers Retirement System Purchases 28,435 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)July 11 at 3:59 AM | marketbeat.comACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares Purchased by Amalgamated BankJuly 11 at 3:29 AM | marketbeat.comAcadia Emerges From Behind The Scenes With A Potential $12 Billion OpportunityJuly 11 at 3:28 AM | msn.comACADIA Pharmaceuticals’ SWOT analysis: stock poised for growth amid pipeline expansionJuly 8, 2025 | investing.comOregon Public Employees Retirement Fund Takes $468,000 Position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)July 8, 2025 | marketbeat.comACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Position Increased by Allspring Global Investments Holdings LLCJuly 6, 2025 | marketbeat.comAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 3, 2025 | businesswire.comAnalysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD), Roivant Sciences (ROIV) and Walgreens Boots Alliance (WBA)July 2, 2025 | theglobeandmail.comStocks Showing Improving Market Leadership: Ionis Pharmaceuticals Earns 84 RS RatingJuly 2, 2025 | msn.com72,125 Shares in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Acquired by Illinois Municipal Retirement FundJuly 2, 2025 | marketbeat.comCRISPR Therapeutics Earns Relative Strength Rating Upgrade; Hits Key ThresholdJuly 1, 2025 | msn.comACADIA Pharmaceuticals (ACAD) Gets a Sell from Goldman SachsJune 28, 2025 | theglobeandmail.comTonix Pharmaceuticals Scores Relative Strength Rating UpgradeJune 27, 2025 | msn.comACAD ACADIA Pharmaceuticals Inc. - Seeking AlphaJune 27, 2025 | seekingalpha.comSG Americas Securities LLC Has $301,000 Stock Position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)June 27, 2025 | marketbeat.comStocks With Rising Composite Ratings: ACADIA PharmaceuticalsJune 26, 2025 | msn.comACADIA Pharmaceuticals (NASDAQ:ACAD) Receives "Market Outperform" Rating from JMP SecuritiesJune 26, 2025 | marketbeat.comACADIA Pharmaceuticals (NASDAQ:ACAD) Receives Buy Rating from HC WainwrightJune 26, 2025 | marketbeat.comACADIA Pharmaceuticals' (ACAD) Buy Rating Reiterated at Needham & Company LLCJune 26, 2025 | marketbeat.comState of Alaska Department of Revenue Purchases Shares of 68,225 ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)June 26, 2025 | marketbeat.comACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Receives Consensus Rating of "Moderate Buy" from BrokeragesJune 26, 2025 | marketbeat.comAcadia Pharmaceuticals price target raised to $38 from $26 at RBC Capital - Investing.comJune 25, 2025 | investing.comACADIA Pharmaceuticals Inc Price vs Fair Value - MorningstarJune 25, 2025 | morningstar.comMStocks Showing Market Leadership: Lyra Therapeutics Earns 93 RS RatingJune 25, 2025 | msn.comAcadia Pharmaceuticals Hosts Inaugural R&D Day Showcasing Pipeline and Long-Term Value DriversJune 25, 2025 | finance.yahoo.com4ACAD : 13 Analysts Assess ACADIA Pharmaceuticals: What You Need To KnowJune 23, 2025 | benzinga.comRoyal Bank Of Canada Issues Positive Forecast for ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock PriceJune 23, 2025 | marketbeat.comAcadia Pharmaceuticals (ACAD) Conducts Inducement Awards to Attract and Retain Top TalentJune 20, 2025 | msn.comYousif Capital Management LLC Makes New $764,000 Investment in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)June 20, 2025 | marketbeat.comHigh Growth Tech Stocks In The US Market June 2025June 19, 2025 | finance.yahoo.comACADIA Pharmaceuticals (NASDAQ:ACAD) shareholders have earned a 21% CAGR over the last three yearsJune 19, 2025 | finance.yahoo.comAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 17, 2025 | businesswire.comGAMMA Investing LLC Increases Stock Holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)June 17, 2025 | marketbeat.comCantor Fitzgerald Sticks to Their Buy Rating for ACADIA Pharmaceuticals (ACAD)June 16, 2025 | theglobeandmail.com13 Biotech Stocks with Huge Upside PotentialJune 13, 2025 | insidermonkey.comRhumbline Advisers Increases Stock Holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)June 13, 2025 | marketbeat.comAssenagon Asset Management S.A. Invests $60.85 Million in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)June 12, 2025 | marketbeat.comUS Appeals Court Confirms Patent Validity of Acadia’s Parkinson’s MedicationJune 11, 2025 | insidermonkey.comAcadia Pharmaceuticals Gets Another Court Win for Parkinson's TreatmentJune 10, 2025 | marketwatch.comUS appeals court confirms patent validity of Acadia's Parkinson's drugJune 10, 2025 | msn.comAnalysts Issue Forecasts for ACAD FY2026 EarningsJune 10, 2025 | marketbeat.comU.S. Court of Appeals for the Federal Circuit Affirms Prior Delaware District Court Rulings in Favor of Acadia in NUPLAZID® (pimavanserin) Composition of Matter PatentJune 9, 2025 | businesswire.comBrokers Offer Predictions for ACAD FY2025 EarningsJune 9, 2025 | marketbeat.comInsider Selling: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Director Sells 14,446 Shares of StockJune 7, 2025 | insidertrades.comJPMorgan Chase & Co. Forecasts Strong Price Appreciation for ACADIA Pharmaceuticals (NASDAQ:ACAD) StockJune 6, 2025 | marketbeat.comACADIA Pharmaceuticals (NASDAQ:ACAD) Upgraded to Strong-Buy at Cantor FitzgeraldJune 6, 2025 | marketbeat.comBofA Securities Lifts ACADIA Pharmaceuticals Inc. (ACAD)’s Price Target To $23, Maintains Neutral RatingJune 6, 2025 | msn.comThe Analyst Verdict: ACADIA Pharmaceuticals In The Eyes Of 11 ExpertsJune 6, 2025 | benzinga.com Get ACADIA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ACAD and its competitors with MarketBeat's FREE daily newsletter. Email Address ACAD Media Mentions By Week ACAD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACAD News Sentiment▼1.340.99▲Average Medical News Sentiment ACAD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACAD Articles This Week▼89▲ACAD Articles Average Week Get ACADIA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ACAD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Genmab A/S News Dr. Reddy's Laboratories News Moderna News Regencell Bioscience News Viatris News Ascendis Pharma A/S News QIAGEN News Blueprint Medicines News BridgeBio Pharma News Verona Pharma PLC American Depositary Share News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACAD) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ACADIA Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ACADIA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
